U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953466) titled 'Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome' on April 07.
Brief Summary: The goal of this clinical trial (via an expanded access Treatment Protocol) is to learn if QRX003 (an investigational drug) applied topically to the skin (including up to the entire body [except the scalp]) works to treat the genetic disease Netherton syndrome. It will also learn about the safety of QRX003. The main questions the trial aims to answer are:
1. Does QRX003 impact the clinical presentation of NS in adults and minors by improving the clinical symptoms (diseased skin area, itch, and discomfort; based on clinical scoring, subjec...